16:02 Dec 20
Glenmark Pharmaceuticals Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Glenmark Pharmaceuticals Ltd.
19/100 Low Financial Strength
Quality12/100 Expensive Valuation
Valuation57/100 Technically Neutral
TechnicalSWOT
Strength
5
Weakness
7
Opportunity
1
Threat
0
43.50K
Market Cap (Cr)
-49.71
PE Ratio
5.15
Price to Book Ratio
48.06
RSI
-12.71 %
Net Profit Margin
Rating Based on 4 Analysts
Buy
50%
Hold
25%
Sell
25%
Buy
Analyst Price Target
The average price target is 1602 with a high estimate of 1894 and low estimate of 1319
Current 1541.65
Disclaimer:The analysis information is for reference only and does not constitude an investment recommendation
SWOT
Download Our App On:
